FDA OKs respiratory-virus test

01/21/2008 | Washington Post (tiered subscription model), The

The FDA has approved the ProFlu+ test designed to accurately detect four common respiratory viruses within three hours. The test, developed by Milwaukee-based Prodesse, could help health professionals quickly determine whether a disease is caused by a respiratory virus, the director of the FDA's Center for Devices and Radiological Health said.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA